Physician profile
Richard Blatter
NPI 1154682565
$4,848.31
in general payments reported to CMS, 2019-2025
42 companies · $834 in 2025
The $834 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $640 · 2021: $770 · 2022: $866 · 2023: $846 · 2024: $729 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.69 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,164.63 | 2019-2025 | Lithovue, Spaceoar System |
| Astellas Pharma US INC | $406.36 | 2020-2024 | Xtandi |
| Janssen Biotech, INC. | $397.15 | 2019-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $350.21 | 2019-2025 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $278.09 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $235.04 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Calyxo, INC. | $187.52 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $177.42 | 2021-2024 | Urolift |
| Pfizer INC. | $139.41 | 2020-2025 | |
| 180 Medical, INC. | $110.79 | 2022-2024 | Gentlecath Glide, Gentlecath |
| Myovant Sciences INC. | $104.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $104.80 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $94.84 | 2024-2025 | Adstiladrin |
| Immunitybio, INC. | $78.38 | 2024-2025 | |
| Coloplast Corp | $77.69 | 2021-2023 | Titan |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $73.29 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $67.64 | 2021-2025 | Endosheath Technology |
| Axonics, INC. | $63.40 | 2022-2024 | Bulkamid, Axonics |
| Endo Pharmaceuticals INC. | $60.70 | 2019-2023 | Aveed, Xiaflex |
| Olympus America INC. | $52.82 | 2020-2025 | Bovie, Uretero-Reno Videoscope, Itind System |
| Dendreon Pharmaceuticals LLC | $50.66 | 2019-2024 | Provenge |
| Antares Pharma, INC. | $48.33 | 2021-2022 | |
| Palette Life Sciences, INC. | $48.21 | 2022 | |
| Allergan, INC. | $46.42 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $44.54 | 2023-2024 | Trelstar |
| Tolmar Pharmaceuticals, INC. | $38.83 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.75 | 2023-2025 | |
| Telix Pharmaceuticals | $37.79 | 2025 | Illuccix |
| Cook Medical LLC | $31.00 | 2019 | |
| Myriad Genetic Laboratories, INC. | $28.67 | 2021-2023 | Prolaris |
| Isoray, INC | $27.42 | 2019-2020 | |
| Inspire Medical Systems, INC. | $25.28 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $19.28 | 2020 | |
| Ambu INC. | $18.22 | 2024 | |
| Abc Home Medical Supply, INC. | $18.09 | 2024 | |
| Neotract INC. | $17.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.71 | 2022 | |
| Tolmar, INC. | $14.89 | 2023 | |
| Convatec INC. | $14.62 | 2023 | |
| Urogen Pharma, INC. | $14.44 | 2022 | |
| Endo USA, INC. | $14.27 | 2024 | Xiaflex |
| Travere Therapeutics, INC. | $8.90 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Blatter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.